Jupiter Wellness Acquisition Corp. Stock: price and insider trades · United States
Jupiter Wellness Acquisition Corp.: what insiders have been doing
Only a handful of insider records exist for Jupiter Wellness Acquisition Corp., the last one from 17 March 2022, too few to describe a trend. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended September 2022 · cache
- 96,335 sharesClass A Common StockSEC:0001264931-22-000063:0
- 96,335 sharesClass A Common StockSEC:0001264931-22-000065:0
- 493,000 shares@ US$10.00100.0% of flowClass A Common StockSEC:0001264931-21-000265:0
- 493,000 shares@ US$10.00100.0% of flowClass A Common StockSEC:0001264931-21-000263:0
4 of 4 declarations
About Jupiter Wellness Acquisition Corp.
Jupiter Wellness Acquisition Corp. is a U.S.-listed special purpose acquisition company (SPAC) rather than a traditional operating business. The company was incorporated in Delaware on September 14, 2021, and was formed to pursue a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target companies. SEC filings and related market disclosures show that its principal executive offices are located at 1061 E. Indiantown Road, Suite 110, Jupiter, Florida 33477, in the United States. The company came to market through a 2021 initial public offering and, at launch, stated an investment focus on healthcare-related targets, including healthcare AI, medical therapeutics, and diagnostics. That healthcare emphasis is the main reason the company is best categorized under Health & Pharma for francophone investors, even though as a SPAC it does not itself sell branded drugs, devices, or consumer health products.
From a competitive standpoint, Jupiter Wellness Acquisition Corp.’s ‘business’ is deal sourcing rather than product execution. Its value proposition depends on management’s ability to identify, negotiate, and complete a transaction with an attractive private company, ideally in a sector where the sponsor believes it has relevant expertise. That makes the company fundamentally different from an industrial or commercial issuer: there is no stable operating footprint, no recurring product revenue, and no direct competitive share in a product market prior to a de-SPAC transaction.
Read moreShow less
In terms of recent milestones, the key corporate event was the announced business combination with Chijet, a China-based automotive group, which was approved by stockholders and closed on June 1, 2023. That transaction materially changed the trajectory of the vehicle associated with the original SPAC structure. For investors looking at SEC Form 4 insider activity, the important analytical point is that post-merger ownership and governance dynamics may differ substantially from the original SPAC framework, so filings should be read in the context of the company’s current post-combination structure.
Overall, Jupiter Wellness Acquisition Corp. should be viewed as a U.S. capital-markets vehicle associated with the NASDAQ/NYSE ecosystem in the United States, with a history rooted in healthcare-focused SPAC sponsorship and a recent transformation through its completed business combination.
